[1] 院存珍, 樊 晨. 原发性肝癌的外科治疗进展[J].中国现代普通外科进展, 2016, 19(2):155-157.
[2] Center MM, Jemal A. International trends in liver cancer incidence rates[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(11):2362-2368.
[3] Zhang H, Ozaki I, Hamajima H, et al. Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activation[J]. Oncol Rep, 2011, 25(1):159-166.
[4] Hanna S, El-Sibai M. Signaling networks of Rho GTPases in cell motility[J]. Cell Signal, 2013, 25(10):1955-1961.
[5] Zhou S, Ye W, Zhang Y, et al. miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway[J]. Am J Transl Res, 2016, 8(7):2992-3002.
[6] Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil:mechanisms of action and clinical strategies[J]. Nat Rev Cancer, 2003, 3(5):330-338.
[7] Guo X, Goessl E, Jin G, et al. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance[J]. Anticancer Res, 2008, 28(1A):9-14.
[8] Zhang N, Yin Y, Xu SJ, et al. 5-Fluorouracil:mechanisms of resistance and reversal strategies.[J]. Molecules, 2008, 13(8):1551-1569.
[9] Cao LQ,Wang XL,Wang Q,et al. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway[J].Acta Pharmacol Sin, 2009, 30(9):1316-1322.
[10] Sharma SS, Pledger WJ. The non-canonical functions of p27(Kip1) in normal and tumor biology[J]. Cell Cycle, 2016, 15(9):1189-1201.
[11] Hoshino D, Koshikawa N, Seiki M. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC[J].J Biol Chem,2011, 286(4):3139-3148.
[12] 马 强, 谢淑丽, 王广义,等. 慢病毒介导靶向P27RF-Rho基因沉默对肝癌细胞侵袭性的影响[J]. 吉林大学学报:医学版, 2016, 42(2):260-265.
[13] 邢光远, 谢淑丽, 邱 伟,等. P27RF-Rho基因沉默对肝癌Bel7402细胞增殖的影响[J]. 吉林大学学报:医学版, 2015, 41(3):542-547.
[14] Tseliou M, Al-Qahtani A, Alarifi S, et al. The role of RhoA, RhoB and RhoC GTPases in cell morphology, proliferation and migration in human cytomegalovirus (HCMV) infected glioblastoma cells[J]. Cell Physiol Biochem, 2016, 38(1):94-109.
[15] Xie S, Zhu M, Lv G, et al. The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells[J]. Med Oncol, 2012, 29(3):1802-1809.
[16] Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21[J]. Cell, 1994, 78(1):67-74.
[17] 谢启超, 胡义德. p27研究进展[J]. 国外医学:肿瘤学分册, 2003, 30(1):48-50.
[18] Satoh T, Kaida D. Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest[J]. Sci Rep, 2016, 6:27829. |